Skip to search formSkip to main contentSkip to account menu

AZD1722

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

tenapanor

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Effects of Tenapanor on Cytochrome P450‐Mediated Drug‐Drug Interactions
Tenapanor (RDX5791, AZD1722) is an inhibitor of sodium/hydrogen exchanger isoform 3 in development for the treatment of… 
2016
2016
A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers
BackgroundTenapanor (RDX5791, AZD1722), a small molecule with minimal systemic availability, is an inhibitor of the sodium… 
2016
2016
Effect of Tenapanor on Interdialytic Weight Gain in Patients on Hemodialysis.
BACKGROUND AND OBJECTIVES Interdialytic weight gain in patients on hemodialysis is associated with adverse cardiovascular… 
2016
2016
Preclinical and Healthy Volunteer Studies of Potential Drug–Drug Interactions Between Tenapanor and Phosphate Binders
Tenapanor (RDX5791, AZD1722), a first‐in‐class small molecule with minimal systemic availability, is an inhibitor of the sodium… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)